Palvella Therapeutics (PVLA) Short-term Investments (2017 - 2026)

Palvella Therapeutics (PVLA) has 7 years of Short-term Investments data on file, last reported at $55.5 million in Q1 2026.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $55.5 million in Q1 2026; TTM through Mar 2026 was $55.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at $9.0 million, down 56.32% from the prior year.
• Short-term Investments for Q1 2026 stood at $55.5 million, up from $9.0 million in the prior quarter.
• Over the last five years, Short-term Investments for PVLA reached as high as $55.5 million in Q1 2026 and fell as low as $8.6 million in Q1 2023.
• Historically, Short-term Investments has averaged $20.0 million across 3 years, with a median of $16.5 million in 2022.
• On a YoY basis, Short-term Investments climbed as much as 44.32% in 2023 and fell as far as 62.75% in 2023.
• Year by year, Short-term Investments stood at $20.5 million in 2022, then plunged by 56.32% to $9.0 million in 2023, then surged by 518.27% to $55.5 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $55.5 million in Q1 2026, $9.0 million in Q4 2023, and $11.9 million in Q3 2023.